PL2729810T3 - Zapalenie mięśni - Google Patents

Zapalenie mięśni

Info

Publication number
PL2729810T3
PL2729810T3 PL12740236T PL12740236T PL2729810T3 PL 2729810 T3 PL2729810 T3 PL 2729810T3 PL 12740236 T PL12740236 T PL 12740236T PL 12740236 T PL12740236 T PL 12740236T PL 2729810 T3 PL2729810 T3 PL 2729810T3
Authority
PL
Poland
Prior art keywords
myositis
Prior art date
Application number
PL12740236T
Other languages
English (en)
Inventor
Gerardus Jozef Maria Pruijn
Wilhelmina Lamberta Leonarda Petronell PLUK
Basilius Gerardus Maria VAN ENGELEN
Original Assignee
Stichting Katholieke Universiteit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Katholieke Universiteit filed Critical Stichting Katholieke Universiteit
Publication of PL2729810T3 publication Critical patent/PL2729810T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
PL12740236T 2011-07-07 2012-07-05 Zapalenie mięśni PL2729810T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161505233P 2011-07-07 2011-07-07
NL2007065 2011-07-07
EP12740236.0A EP2729810B1 (en) 2011-07-07 2012-07-05 Myositis
PCT/NL2012/050482 WO2013006059A1 (en) 2011-07-07 2012-07-05 Myositis

Publications (1)

Publication Number Publication Date
PL2729810T3 true PL2729810T3 (pl) 2019-03-29

Family

ID=47437256

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12740236T PL2729810T3 (pl) 2011-07-07 2012-07-05 Zapalenie mięśni

Country Status (6)

Country Link
US (1) US20140221233A1 (pl)
EP (1) EP2729810B1 (pl)
CN (1) CN103688173B (pl)
PL (1) PL2729810T3 (pl)
SI (1) SI2729810T1 (pl)
WO (1) WO2013006059A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9778250B2 (en) 2011-05-10 2017-10-03 The Brigham And Women's Hospital, Inc. Detecting inclusion body myositis
EP3033622A4 (en) * 2013-08-13 2017-05-31 The Brigham and Women's Hospital, Inc. Sensitive diagnostic assay for inclusion body myositis
CN104422763B (zh) * 2013-08-23 2017-03-22 中日友好医院 抗原组在制备诊断疾病的试剂盒中的用途和试剂盒
EP3220948B1 (en) * 2014-11-17 2019-09-18 Stiftelsen Vectis Novel autoantigen in idiopathic inflammatory myopathies
CA3043823A1 (en) * 2015-11-17 2017-05-26 The Regents Of The University Of Colorado, A Body Corporate Novel multiplex assays to diagnose or evaluate diseases or disorders in mammals
EP3293520B1 (en) 2016-09-09 2019-11-06 Euroimmun Medizinische Labordiagnostika AG A method for the production of an polypeptide
CN110554202B (zh) * 2019-10-14 2021-01-19 南京鼓楼医院 趋化因子ccl8在制备皮肌炎病情及预后评估试剂中的应用
CN114350820B (zh) * 2022-01-20 2023-10-20 湖北省农业科学院畜牧兽医研究所 一种与猪胴体性状相关的分子标记及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8544591A (en) * 1990-09-07 1992-03-30 Board Of Regents Of The University Of Oklahoma, The Antigens associated with polymyositis and with dermatomyositis
WO2002004613A2 (en) * 2000-07-07 2002-01-17 University Of North Carolina At Chapel Hill Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same
US20040072190A1 (en) * 2001-09-28 2004-04-15 Henry Yue Hydrolases
EP1716887B1 (en) 2005-04-25 2008-03-19 Sahltech I Göteborg AB Treatment of inclusion body myositis
CN101522910A (zh) * 2006-06-12 2009-09-02 佐拉生物科学有限公司 肌病的诊断方法
US9778250B2 (en) * 2011-05-10 2017-10-03 The Brigham And Women's Hospital, Inc. Detecting inclusion body myositis

Also Published As

Publication number Publication date
SI2729810T1 (sl) 2019-02-28
CN103688173A (zh) 2014-03-26
US20140221233A1 (en) 2014-08-07
EP2729810B1 (en) 2018-10-10
WO2013006059A1 (en) 2013-01-10
EP2729810A1 (en) 2014-05-14
CN103688173B (zh) 2017-03-22

Similar Documents

Publication Publication Date Title
DK3798230T3 (en) Terapeutiske antistoffer
EP2790561A4 (en) DISHWASHER
EP2755962A4 (en) AZAINDAZOLES
EP2715659A4 (en) ABOUT FEED
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
EP2723631A4 (en) QUADFOILER
EP2776444A4 (en) dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
SI2729810T1 (sl) Miozitis
EP2695208A4 (en) MICRO-THERMOCOUPLE
EP2679138A4 (en) Borescope
EP2708561A4 (en) BIO-PIN
DK2770906T3 (en) Applanationstonometer
EP2684382A4 (en) EARPHONES
EP2698098A4 (en) campimeter
EP2694655A4 (en) pavec
EP2702929A4 (en) campimeter
GB201101727D0 (en) Obuoy
GB201100001D0 (en) TidySqueeze2
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5171P (en) Sunparamiho Mandevilla xamabilis
AU5031P (en) BESYS Beschorneria yuccoides
AU5026P (en) Goldstrike Agapanthus inapertus
AP00723S1 (en) Autorickshaw
AU2011303V (en) Silverado Dianella tasmanica